REGENXBIO Inc. (RGNX) Form 424B5 — Jul 17, 2026
REGENXBIO Inc. priced a public offering of 10.0 million shares of common stock and 1.1 million pre-funded warrants at $9.00 per share, a 19.6% discount to the July 16 closing price of $11.20. The aggregate public offering price is approximately $100 million, with underwriters Morgan Stanley, J.P. Morgan, Leerink Partners, and Mizuho acting as representatives.
Key figures
- Gross Proceeds
- 100,034,889
- Offering Price
- 9
- Shares Offered
- 10003889
- Closing Price
- 11.2
- Greenshoe Shares
- 1667250
- Dilution Per Share
- 7.14
- Underwriting Discount
- 0.54
- Warrants Offering Price
- 8.9999
- Cash Position As Of June30
- 105,500,000
- Expected Abb Vie Milestone
- 100,000,000
- Pre Funded Warrants Offered
- 1111111
- Shares Outstanding Post Offering
- 61621122
Price after filing
1 day: 0.0%7 days: -1.6%30 days: +8.8%
Close on the filing date to close N calendar days later (from $9.89). Historical, not a forecast.
AI analysis
Red flags5 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.